StartUps
– The 12-week Phase IIb study involving 79 patients with active rheumatoid arthritis met all its primary efficacy endpoints. – Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin...
Hi, what are you looking for?
– The 12-week Phase IIb study involving 79 patients with active rheumatoid arthritis met all its primary efficacy endpoints. – Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin...
– Facebook Joins S&P 500 Facebook has been in the news quite a bit this week. First, Standard & Poor‘s (S&P), a division...
– Moovit will use the investment to enhance services in the 100 cities in which it operates, while expanding to new markets. – –...
– Six weeks after the Nasdaq IPO of the DIY website developer, the share price has risen 67% and the market cap is above...
– The funding will be used by Dr. Ciechanover in the development of drugs for the treatment of Kidney disorders as well as Ovarian...
– – Just over two weeks ago, on December 3rd, Jewish Business News reported on the launching of an initial public offering (IPO) that...
– Tzameret Fuerst, co-founder of Israeli start-up Circ MedTech, behind the development of PrePex, claims to be capable of providing an effective medical device...
– – Starting your own business is never easy, especially without advice. But even for those who get advice from family, friends, colleagues or trusted...
– Why ? Because : “Israel took third place in the “Innovation” category in the latest Global Competitiveness Ranking published by the World Economic Forum....
– QUICK UPDATE to Jewish Business News Story published December 9th, 2013 – Joseph Neubauer / Getty Management and food services company Aramark Holdings...